DIPLOMAT PHARM

 DPLOのチャート


 DPLOの企業情報

symbol DPLO
会社名 Diplomat Pharmacy Inc (DIPLOMAT PHARM)
分野(sector)   
産業(industry)   
業種 ヘルスケア施設_サ―ビス   医療関連(Health Care)
概要 ディプロマット・パーマシー(Diplomat Pharmacy Inc.)は各種バイオテクノロジー及び専門的医薬品メーカーの処方箋を調達・配付・販売する専門的薬局事業を運営する。同社は専門的薬局サービス事業を運営する。同社は腫瘍学、免疫学、肝炎、多発性硬化症、特殊注入及慢性疾患患者のための投薬管理プログラムを中心とする。同社は小売業者と独立系薬局団体、病院と保健システムの全国ネットワーク向けに専門的薬局支援サービスを提供する。同社は、専門的医薬品調剤、小売専門サービス、病院と保健システム・サービス、ハブサービス等のサービスを提供する。同社の患者ケア・システムは患者アドヒアランス・安全を調整・追跡するために使用される。  ディプロマット・ファ―マシ―は米国の専門薬局。腫瘍学、免疫学、肝炎、多発性硬化症、HIVや特殊点滴療法などの専門治療分野において、複雑な慢性疾患の治療として定期的に投与される専門薬を中心に事業を展開。複雑な投薬療法、リフィル処方箋、サ―ドパ―ティの資金調達支援プログラム、副作用の管理、および支持の順守監視などのサ―ビスを提供する。  Diplomat Pharmacy, Inc. engages in the provision of specialty pharmacy and infusion services. It operates through the Specialty and Pharmacy Benefit Management segments. The Specialty segment offers a range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost specialty drugs, and a wide range of applications. The Pharmacy Benefit Management segment provides services designed to help the customers reduce the cost and manage the complexity of their prescription drug programs. The company was founded by Dale Hagerman and Philip Hagerman in 1975 and is headquartered in Flint, MI.
本社所在地 4100 S. Saginaw Street Flint MI 48507 USA
代表者氏名 Brian T. Griffin
代表者役職名 Chairman of the Board Chief Executive Officer
電話番号 +1 888-720-4450
設立年月日 1975年
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 2335人
url www.diplomat.is
nasdaq_url
adr_tso
EBITDA (百万ドル) 138.67300
終値(lastsale)
時価総額(marketcap)
時価総額 (百万ドル) 423.84680
売上高 (百万ドル) 5492.52400
企業価値(EV) (百万ドル) 1040.53080
当期純利益 (百万ドル) -303.37400
決算概要 BRIEF: For the fiscal year ended 31 December 2018 Diplomat Pharmacy Inc revenues increased 22% to $5.49B. Net loss before extraordinary items totaled $303.4M vs. income of $7.7M. Revenues reflect PBM segment increase from $12.4M to $729.5M. Net loss reflects Goodwill impairments increase from $0K to $225M (expense) Impairments of definite-lived intangible increase from $0K to $82.7M (expense).

 DPLOのテクニカル分析


 DPLOのニュース

   ALEX, GNRC, CRMT shuffled in S&P index changes  2020/02/07 22:29:39 Seeking Alpha
Alexander & Baldwin (NYSE:ALEX) is moving into the S&P SmallCap 600 from the MidCap 400 to replace Diplomat Pharmacy (NYSE:DPLO), set to be acquired by Uni
   WeissLaw LLP Investigates Diplomat Pharmacy, Inc. | MarketScreener  2019/12/12 20:01:03 MarketScreener
NEW YORK, Dec. 12, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Diplomat Pharmacy, Inc. in… | December 12, 2019
   SHAREHOLDER ALERT: WeissLaw LLP Investigates Diplomat Pharmacy, Inc.  2019/12/12 20:00:00 PR Newswire
NEW YORK, Dec. 12, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO) in connection with the proposed acquisition of the Company…
   SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of DIPLOMAT PHARMACY, INC - DPLO  2019/12/10 23:18:00 PR Newswire
NEW YORK, Dec. 10, 2019 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO)…
   UnitedHealth to Buy Diplomat Pharmacy for $4 aShare, Combine Firm With OptumRx  2019/12/09 16:41:42 The Street
Diplomat, the Flint, Mich., pharmacy- and infusion-services provider, had considered a number of strategic options.
   ALEX, GNRC, CRMT shuffled in S&P index changes  2020/02/07 22:29:39 Seeking Alpha
Alexander & Baldwin (NYSE:ALEX) is moving into the S&P SmallCap 600 from the MidCap 400 to replace Diplomat Pharmacy (NYSE:DPLO), set to be acquired by Uni
   WeissLaw LLP Investigates Diplomat Pharmacy, Inc. | MarketScreener  2019/12/12 20:01:03 MarketScreener
NEW YORK, Dec. 12, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Diplomat Pharmacy, Inc. in… | December 12, 2019
   SHAREHOLDER ALERT: WeissLaw LLP Investigates Diplomat Pharmacy, Inc.  2019/12/12 20:00:00 PR Newswire
NEW YORK, Dec. 12, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO) in connection with the proposed acquisition of the Company…
   SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of DIPLOMAT PHARMACY, INC - DPLO  2019/12/10 23:18:00 PR Newswire
NEW YORK, Dec. 10, 2019 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO)…
   UnitedHealth to Buy Diplomat Pharmacy for $4 aShare, Combine Firm With OptumRx  2019/12/09 16:41:42 The Street
Diplomat, the Flint, Mich., pharmacy- and infusion-services provider, had considered a number of strategic options.

 関連キーワード  (ヘルスケア施設_サ―ビス 米国株 DIPLOMAT PHARM DPLO )

 twitter  (公式ツイッターやCEOツイッターなど)